Haemonetics Corp. plans to lay off about 170 workers as it integrates its $61 million purchase, GlobalMed Technologies, spending $15 million with an eye toward saving $14 million a year going forward.

Haemonetics Corp. (NYSE:HAE) plans to lay off about 170 workers and close facilities in Phoenix and Chicago as it integrates its new, $61 million acquisition, GlobalMed Technologies (OTC:GLOB).

The Braintree, Mass.-based blood management firm said the integration will cost about $15 million and save $14 million a year thereafter. CEO Brian Concannon and CFO Chris Lindop told analysts during a conference call that the layoffs will include employees from both companies. The move is also prompting Haemonetics to abandon development of its Symphony blood bank donation management software and its next generation of platelet apheresis products. Discontinuing development of the Symphony product, which the company said it will continue to support, means a $4 million non-cash write-off charge; abandoning the platelet apheresis operation will incur a $12 million write-down.